| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.091 | 0.1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |